Feb 2021 $98 M No. 6 $50 to $250 million 38
Personal Genome Diagnostics Inc.: Raise no. 6, Feb 2021 × Investors in this round 38 investors had bought by the notice of Feb 23, 2021: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $98 M of $98 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jack A. Crowley · Executive Officer Megan A. Bailey · Executive Officer, Director Samuel A. Anguioli · Executive Officer Scott A. Gotshall · Executive Officer James A. LaFrance · Director Justin A. Klein · Director Kavita A. Patel · Director Kevin A. Reidy · Director Lily A. Li · Director Luis A. Diaz, Jr. · Director Victor A. Velculescu · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Megan Bailey, Interim Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 23, 2021. Read the notice at the SEC .
equity SEC May 2020 $3 M No. 5 $2 to $10 million 2
Personal Genome Diagnostics Inc.: Raise no. 5, May 2020 × Investors in this round 2 investors had bought by the notice of May 26, 2020: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $4 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jack A. Crowley · Executive Officer Megan A. Bailey · Executive Officer Sam A. Anguioli · Executive Officer Garry A. Nicholson · Director James A. LaFrance · Director Jason A. Fuller · Director Justin A. Klein · Director Kavita A. Patel · Director Luis A. Diaz, Jr. · Director Victor A. Velculescu · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Megan Bailey, Interim Chief Executive Officer. Source: SEC Form D, newest notice filed May 26, 2020. Read the notice at the SEC .
debt, options SEC Jun 2019 $5 M No. 4 $2 to $10 million 1
Personal Genome Diagnostics Inc.: Raise no. 4, Jun 2019 × Investors in this round 1 investor had bought by the notice of Jun 24, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $20 M offered; $15 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Douglas A. Ward · Executive Officer, Director Sam A. Anguioli · Executive Officer Garry A. Nicholson · Director Jack A. Crowley · Director James A. LaFrance · Director Jason A. Fuller · Director Justin A. Klein · Director Kavita A. Patel · Director Luis A. Diaz, Jr. · Director Victor A. Velculescu · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Douglas Ward, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 24, 2019. Read the notice at the SEC .
debt, options SEC Oct 2017 $65 M No. 3 $50 to $250 million 12
Personal Genome Diagnostics Inc.: Raise no. 3, Oct 2017 × Investors in this round 12 investors had bought by the notice of Oct 30, 2017: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $65 M of $112 M offered; $46 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Douglas A. Ward · Executive Officer, Director Sam A. Anguioli · Executive Officer William A. Stevens · Executive Officer James A. LaFrance · Director Justin A. Klein · Director Luis A. Diaz, Jr. · Director Victor A. Velculescu · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Douglas Ward, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 30, 2017. Read the notice at the SEC .
equity SEC Oct 2015 $20 M No. 2 $10 to $50 million 22
Personal Genome Diagnostics Inc.: Raise no. 2, Oct 2015 × Investors in this round 22 investors had bought by the notice of Nov 6, 2015: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $21 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Anthony A. Newton · Executive Officer Jeff A. Boschwitz · Executive Officer Luis A. Diaz, Jr. · Executive Officer, Director Sam A. Anguioli · Executive Officer Victor A. Velculescu · Executive Officer, Director William A. Stevens · Executive Officer Justin A. Klein · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Victor Velculescu, Secretary. Source: SEC Form D, newest notice filed Nov 6, 2015. Read the notice at the SEC .
equity SEC Mar 2014 $2 M No. 1 $2 to $10 million 2
Personal Genome Diagnostics Inc.: Raise no. 1, Mar 2014 × Investors in this round 2 investors had bought by the notice of Mar 17, 2014: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken $100,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $57,500
Finders' fees none
Paid to its own people $150,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Maryland People named in the notice Anthony J. Newton · Executive Officer Luis A. Diaz, Jr. · Executive Officer, Director, Promoter Victor A. Velculescu · Executive Officer, Director, Promoter William J. Stevens · Executive Officer Bert J. Vogelstein · Promoter Kenneth W. Kinzler · Promoter Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round John K. Dierkes (CRD 1629115) · broker-dealer Pickwick Capital Partners, LLC (CRD 130672) · White Plains, New York Sold in MD Signed by Luis A. Diaz, Jr., President. Source: SEC Form D, newest notice filed Mar 17, 2014. Read the notice at the SEC .
equity SEC